Karen Carty
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Trial of Gemcitabine, Pembrolizumab and IMM-101 as First Line Treatment in Patients With Metastatic Pancreatic Cancer (NCT06498518) | Karen Carty | 2024-06-17 |
Track Karen Carty automatically
Every clearance here is in the API, with alerts when new ones post.